411 related articles for article (PubMed ID: 22749192)
21. Synthesis, Cytotoxicity and Molecular Docking Studies of the 9-Substituted 5-Styryltetrazolo[1,5-c]quinazoline Derivatives.
Mphahlele MJ; Gildenhuys S; Parbhoo N
Molecules; 2017 Oct; 22(11):. PubMed ID: 29072619
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
Liu LT; Yuan TT; Liu HH; Chen SF; Wu YT
Bioorg Med Chem Lett; 2007 Nov; 17(22):6373-7. PubMed ID: 17889528
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antitumor activity of some novel quinazoline derivatives bearing the biologically active thione moiety.
Ghorab MM; El-Sayed Barakat S; Saker HM; Abd Rabo MM
Arzneimittelforschung; 2006; 56(9):665-70. PubMed ID: 17063643
[TBL] [Abstract][Full Text] [Related]
24. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.
Al-Obaid AM; Abdel-Hamide SG; El-Kashef HA; Abdel-Aziz AA; El-Azab AS; Al-Khamees HA; El-Subbagh HI
Eur J Med Chem; 2009 Jun; 44(6):2379-91. PubMed ID: 18950904
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and anticancer activity of Indolin-2-one derivatives bearing the 4-thiazolidinone moiety.
Wang S; Zhao Y; Zhu W; Liu Y; Guo K; Gong P
Arch Pharm (Weinheim); 2012 Jan; 345(1):73-80. PubMed ID: 21932254
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro antitumor evaluation of primary amine substituted quinazoline linked benzimidazole.
Paul K; Sharma A; Luxami V
Bioorg Med Chem Lett; 2014 Jan; 24(2):624-9. PubMed ID: 24360999
[TBL] [Abstract][Full Text] [Related]
28. Exploring epidermal growth factor receptor (EGFR) inhibitor features: the role of fused dioxygenated rings on the quinazoline scaffold.
Chilin A; Conconi MT; Marzaro G; Guiotto A; Urbani L; Tonus F; Parnigotto P
J Med Chem; 2010 Feb; 53(4):1862-6. PubMed ID: 20095624
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains.
Cao SL; Feng YP; Jiang YY; Liu SY; Ding GY; Li RT
Bioorg Med Chem Lett; 2005 Apr; 15(7):1915-7. PubMed ID: 15780632
[TBL] [Abstract][Full Text] [Related]
30. New derivatives of quinazoline and 1, 2-dihydroquinazoline n3-oxide with expected antitumor activity.
Mikiciuk-Olasik E; Baszczak-Swiatkiewiz K; Zurek E; Krajewska U; Rózalski M; Kruszyński R; Bartczak TJ
Arch Pharm (Weinheim); 2004 May; 337(5):239-46. PubMed ID: 15095417
[TBL] [Abstract][Full Text] [Related]
31. Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity.
Xu YY; Li SN; Yu GJ; Hu QH; Li HQ
Bioorg Med Chem; 2013 Oct; 21(19):6084-91. PubMed ID: 23962660
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and antitumour activity of bisquinoline derivatives connected by 4-oxy-3-fluoroaniline moiety.
Li S; Huang Q; Liu Y; Zhang X; Liu S; He C; Gong P
Eur J Med Chem; 2013 Jun; 64():62-73. PubMed ID: 23644189
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline.
Cao SL; Han Y; Yuan CZ; Wang Y; Xiahou ZK; Liao J; Gao RT; Mao BB; Zhao BL; Li ZF; Xu X
Eur J Med Chem; 2013 Jun; 64():401-9. PubMed ID: 23665106
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and cytotoxicity studies of novel 2-Hydrazonylpyrido[2,3-b]pyrazin-3(4H)-ones.
Zhang G; Liu Y; Wang S; Zhou C; Huang Q; Gong P
Arch Pharm (Weinheim); 2012 Jan; 345(1):49-56. PubMed ID: 21953529
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors.
Jung FH; Pasquet G; Lambert-van der Brempt C; Lohmann JJ; Warin N; Renaud F; Germain H; De Savi C; Roberts N; Johnson T; Dousson C; Hill GB; Mortlock AA; Heron N; Wilkinson RW; Wedge SR; Heaton SP; Odedra R; Keen NJ; Green S; Brown E; Thompson K; Brightwell S
J Med Chem; 2006 Feb; 49(3):955-70. PubMed ID: 16451062
[TBL] [Abstract][Full Text] [Related]
36. Novel EGFR inhibitors prepared by combination of dithiocarbamic acid esters and 4-anilinoquinazolines.
Li RD; Zhang X; Li QY; Ge ZM; Li RT
Bioorg Med Chem Lett; 2011 Jun; 21(12):3637-40. PubMed ID: 21570843
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro antitumor activities of novel 4-anilinoquinazoline derivatives.
Chandregowda V; Kush AK; Chandrasekara Reddy G
Eur J Med Chem; 2009 Jul; 44(7):3046-55. PubMed ID: 18771819
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
Rao GW; Xu GJ; Wang J; Jiang XL; Li HB
ChemMedChem; 2013 Jun; 8(6):928-33. PubMed ID: 23640754
[TBL] [Abstract][Full Text] [Related]
40. Semi-synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol derivatives.
Wang P; Bi XL; Guo YM; Cao JQ; Zhang SJ; Yuan HN; Piao HR; Zhao YQ
Eur J Med Chem; 2012 Sep; 55():137-45. PubMed ID: 22840493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
